The toxoplasma serological status of 50 patients with systemic lupus erythematosus (SLE) was compared with that of 50 healthy controls; high titres of toxoplasma antibody were significantly more common in the patients with SLE. These titres did not correlate with any of the routinely measured indices in SLE nor with the patients' prior treatment. A case history is used to illustrate the difficulty in diagnosing toxoplasmosis in the presence of SLE.
Toxoplasmosis and systemic lupus erythematosus (SLE) produce similar symptoms, such as lymphadenopathy, arthralgia, and fever, and increased awareness of these conditions and refinements in 'diagnostic markers' have led to both conditions being recognised more often. We present a case history to highlight the problems faced when attempting to diagnose toxoplasmosis in the presence of SLE. The persistently high toxoplasma antibody levels found in the patient described prompted this study of the toxoplasma serological status in a cohort of patients with SLE. ment. Further investigations showed: antinuclear antibody titre 1/6000 (IgG class), 34% DNA binding (normal <5%), rheumatoid factor tests negative, polyclonal increases in serum IgA, IgM, and IgG, and a skin biopsy specimen which showed a positive lupus band test. Over the next three years she was treated with hydroxychloroquine and subsequently steroids, leading to resolution of the lymphadenopathy and improvement in joint symptomatology. At this time the toxoplasma serology showed a dye test titre 1/1024 and IgM antibody titre <1/10.
In 1986 she developed painful vasculitic leg ulcers and the investigations showed antinuclear antibody titre 1/6400, double stranded DNA (dsDNA) antibodies negative, and C3dg 18 U/ml (moderate increase This study indicates a significant difference in the number of positive titres of toxoplasma antibody in patients with SLE measured by the dye test compared with healthy controls. It would be unwise to place too much emphasis on this point, however, because the difference between the two groups is mostly due to a greater number of patients having low toxoplasma antibody titres (1/8). More importantly, the number of strong positives by the latex agglutination and dye tests in the patients with SLE is significantly higher than in the controls ( 1 out of 50 compared with two out of 48 in the latex agglutination test Studies have shown that steroid use is a major cause of the increased infection rates in lupus patients. Our patients with either negative, low, or high toxoplasma antibody levels had not been treated differently. To assess fully the significance of immunosuppressive treatment in SLE and toxoplasmosis an untreated SLE control group would be required.
In conclusion, our results suggest that patients with SLE may be more likely to have positive toxoplasma serology, and that some have particularly high antibody titres. There is no evidence that the results are false positives and the increased toxoplasma antibody levels do not seem to be part of a polyclonal increase in immunoglobulins. Our findings of higher than expected toxoplasma antibody levels in lupus patients may be important in the interpretation of toxoplasma serology in such subjects. The possibility that some symptoms and signs in patients with SLE may be due to toxoplasma infection should not be ignored. 
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